-
May 09, 2013
Teva's partnership with Alexza looks like an expensive gamble.
-
May 08, 2013
Amgen really needs the pipeline to come through to support this valuation.
-
May 03, 2013
Teva's present-day momentum is weak, but the value could appeal to patient long-term investors.
-
April 02, 2013
While it’s a tech powerhouse, the natural gas game is quickly changing Israel’s economy for the good. The recent ...
-
February 14, 2013
OncoGenex Pharmaceuticals, Inc. (OGXI) recently announced that it is looking to move its oncology candidate, ...
-
February 12, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced that it has enrolled the first patient in the phase IV ...
-
February 08, 2013
Teva Pharmaceutical Industries (TEVA) reported fourth quarter earnings of $1.32 per American Depositary Share (ADS), ...
-
February 04, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently terminated its collaboration with CureTech Ltd. for the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
We are in the midst of the fourth quarter earnings season and it is once again time to review the players in the ...
-
January 29, 2013
Eli Lilly & Company (LLY) reported fourth quarter 2012 adjusted earnings per share of 85 cents, well above the Zacks ...
-
January 24, 2013
Teva Pharmaceutical Industries Ltd. (TEVA) recently announced disappointing top-line results from a study evaluating ...
-
January 11, 2013
Isis Pharmaceuticals, Inc. (ISIS) recently provided an update on its pipeline. Isis Pharma boasts of a robust ...
-
January 07, 2013
Global Pharmaceuticals, the generic division of Impax Laboratories, Inc. (IPXL), a specialty pharmaceutical company, ...
-
January 07, 2013
The HealthCare unit of Bayer AG (BAYRY) recently received the necessary regulatory approval from the Federal Trade ...
-
December 31, 2012
Mylan Inc. (MYL) recently announced that it has launched its generic version of Teva's (TEVA) Nordette 28 Tablets ...
-
December 20, 2012
Teva (TEVA) recently signed an agreement for the establishment of a business venture in South Korea. Under the ...
-
December 14, 2012
The US Supreme Court will soon hear a case which will determine whether "pay-for-delay" agreements between drug ...
-
December 12, 2012
The Nasdaq remains relatively unchanged, the S&P 500 has moved up 0.2% and the Dow is up 0.2% after the morning's ...
-
December 06, 2012
The pharmaceutical industry is slowly showing signs of recovery from one of the biggest patent cliffs in recent ...
